IN8bio downgraded to Hold from Buy at JonesResearch
PremiumThe FlyIN8bio downgraded to Hold from Buy at JonesResearch
3M ago
IN8bio announces clinical data on INB-100, INB-200
Premium
The Fly
IN8bio announces clinical data on INB-100, INB-200
3M ago
IN8bio reports Q2 EPS (19c), consensus (17c)
Premium
The Fly
IN8bio reports Q2 EPS (19c), consensus (17c)
3M ago
IN8bio announces multiple presentations at ISCT 2024
PremiumThe FlyIN8bio announces multiple presentations at ISCT 2024
5M ago
IN8bio announces INB-200 Phase 1 data in newly diagnosed glioblastoma
Premium
The Fly
IN8bio announces INB-200 Phase 1 data in newly diagnosed glioblastoma
6M ago
IN8bio presented data on gamma-delta T cell manufacturing platform
Premium
The Fly
IN8bio presented data on gamma-delta T cell manufacturing platform
6M ago
IN8bio: Data for Gamma-Delta nsCAR-T cell therapy platform presented at AACR
PremiumThe FlyIN8bio: Data for Gamma-Delta nsCAR-T cell therapy platform presented at AACR
7M ago
IN8bio initiated with a Buy at Laidlaw
Premium
The Fly
IN8bio initiated with a Buy at Laidlaw
8M ago
IN8bio initiated with a Buy at JonesResearch
Premium
The Fly
IN8bio initiated with a Buy at JonesResearch
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100